PureTech Health plc (PRTC) Current Deferred Revenue (2019 - 2021)
PureTech Health (PRTC) has disclosed Current Deferred Revenue for 2 consecutive years, with $65000.0 as the latest value for Q4 2021.
- On a quarterly basis, Current Deferred Revenue fell 95.58% to $65000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $65000.0, a 95.58% decrease, with the full-year FY2021 number at $65000.0, down 95.58% from a year prior.
- Current Deferred Revenue was $65000.0 for Q4 2021 at PureTech Health, down from $1.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.5 million in Q4 2020 to a low of $65000.0 in Q4 2021.